{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:24:37Z","timestamp":1792441477117,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202201ZYTS293"],"award-info":[{"award-number":["YDZJ202201ZYTS293"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01760-w","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T13:20:09Z","timestamp":1759152009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ulinastatin protects against cisplatin-induced ovarian damage via Nrf2\/Keap1 pathway"],"prefix":"10.1186","volume":"18","author":[{"given":"Liping","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiquan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeming","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"1760_CR1","first-page":"9","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9\u201329.","journal-title":"CA Cancer J Clin"},{"key":"1760_CR2","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/cncr.26459","volume":"118","author":"JM Letourneau","year":"2012","unstructured":"Letourneau JM, Ebbel EE, Katz PP, Katz A, Ai WZ, Chien AJ, Melisko ME, Cedars MI, Rosen MP. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2012;118:1710\u20137.","journal-title":"Cancer"},{"key":"1760_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/bjc.1990.58","volume":"61","author":"PF Bruning","year":"1990","unstructured":"Bruning PF, Pit MJ, de Jong-Bakker M, van den Ende A, Hart A, van Enk A. Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer. Br J Cancer. 1990;61:308\u201310.","journal-title":"Br J Cancer"},{"key":"1760_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1517\/14656566.8.3.279","volume":"8","author":"H Jeanes","year":"2007","unstructured":"Jeanes H, Newby D, Gray GA. Cardiovascular risk in women: the impact of hormone replacement therapy and prospects for new therapeutic approaches. Expert Opin Pharmacother. 2007;8:279\u201388.","journal-title":"Expert Opin Pharmacother"},{"key":"1760_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ygyno.2004.12.019","volume":"97","author":"J Carter","year":"2005","unstructured":"Carter J, Rowland K, Chi D, Brown C, Abu-Rustum N, Castiel M, Barakat R. Gynecologic cancer treatment and the impact of cancer-related infertility. Gynecol Oncol. 2005;97:90\u20135.","journal-title":"Gynecol Oncol"},{"key":"1760_CR6","doi-asserted-by":"publisher","first-page":"222ra218","DOI":"10.1126\/scitranslmed.3007154","volume":"6","author":"Y Ma","year":"2014","unstructured":"Ma Y, Chapman J, Levine M, Polireddy K, Drisko J, Chen Q. High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci Transl Med. 2014;6:222ra218.","journal-title":"Sci Transl Med"},{"key":"1760_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/humupd\/7.6.535","volume":"7","author":"D Meirow","year":"2001","unstructured":"Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update. 2001;7:535\u201343.","journal-title":"Hum Reprod Update"},{"key":"1760_CR8","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1126\/science.1071965","volume":"296","author":"MM Matzuk","year":"2002","unstructured":"Matzuk MM, Burns KH, Viveiros MM, Eppig JJ. Intercellular communication in the mammalian ovary: oocytes carry the conversation. Science. 2002;296:2178\u201380.","journal-title":"Science"},{"key":"1760_CR9","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1634\/theoncologist.2012-0172","volume":"17","author":"I Ben-Aharon","year":"2012","unstructured":"Ben-Aharon I, Meizner I, Granot T, Uri S, Hasky N, Rizel S, Yerushalmi R, Sulkes A, Stemmer SM. Chemotherapy-induced ovarian failure as a prototype for acute vascular toxicity. Oncologist. 2012;17:1386\u201393.","journal-title":"Oncologist"},{"key":"1760_CR10","first-page":"2720","volume":"13","author":"S Fang","year":"2020","unstructured":"Fang S, Li P, Zhu C, Han X, Bao P, Guo W. Research progress of Ulinastatin in the treatment of liver diseases. Int J Clin Exp Pathol. 2020;13:2720\u20136.","journal-title":"Int J Clin Exp Pathol"},{"key":"1760_CR11","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/SHK.0000000000001104","volume":"50","author":"C Cao","year":"2018","unstructured":"Cao C, Yin C, Shou S, Wang J, Yu L, Li X, Chai Y. Ulinastatin protects against LPS-Induced acute lung injury by attenuating TLR4\/NF-kappaB pathway activation and reducing inflammatory mediators. Shock. 2018;50:595\u2013605.","journal-title":"Shock"},{"key":"1760_CR12","doi-asserted-by":"publisher","first-page":"102767","DOI":"10.1016\/j.tice.2025.102767","volume":"93","author":"AAA Al-Khawalde","year":"2025","unstructured":"Al-Khawalde AAA, Abukhalil MH, Althunibat OY, Jaber FA, Alaryani FS, Saleh AM, Albalawi AE, Alhasani RH. Taxifolin mitigates cisplatin-induced testicular damage by reducing inflammation, oxidative stress, and apoptosis in mice. Tissue Cell. 2025;93:102767.","journal-title":"Tissue Cell"},{"key":"1760_CR13","unstructured":"Wang Z, Zhao L, Ren L, Yang F. Vindoline mitigates cisplatin-mediated kidney damage by alleviating redox imbalance, apoptosis and inflammation through extracellular signal-regulated kinase pathway modulation. J Physiol Pharmacol 2024, 75."},{"key":"1760_CR14","doi-asserted-by":"crossref","unstructured":"Tong X, Zhu X, Wang X, Xu Y, Huang P, Zhou L, Ji Y, Wu L. Oxidative Stress-Related KEAP1 and NRF2 genes contributed to the risk of epithelial ovarian Cancer. Biochem Genet 2025.","DOI":"10.1007\/s10528-025-11044-z"},{"key":"1760_CR15","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s10787-024-01549-1","volume":"32","author":"T Kaur","year":"2024","unstructured":"Kaur T, Sidana P, Kaur N, Choubey V, Kaasik A. Unraveling neuroprotection in parkinson\u2019s disease: Nrf2-Keap1 pathway\u2019s vital role amidst pathogenic pathways. Inflammopharmacology. 2024;32:2801\u201320.","journal-title":"Inflammopharmacology"},{"key":"1760_CR16","doi-asserted-by":"publisher","first-page":"e370606","DOI":"10.1590\/acb370606","volume":"37","author":"X Wu","year":"2022","unstructured":"Wu X, Jiao W, Chen J, Tao Y, Zhang J, Wang Y. Ulinastatin alleviates early brain injury after intracerebral hemorrhage by inhibiting oxidative stress and neuroinflammation via ROS\/MAPK\/Nrf2 signaling pathway. Acta Cir Bras. 2022;37:e370606.","journal-title":"Acta Cir Bras"},{"key":"1760_CR17","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s10753-021-01505-z","volume":"44","author":"F Chen","year":"2021","unstructured":"Chen F, Zhu J, Wang W. Ulinastatin attenuates LPS-Induced inflammation and inhibits Endoplasmic reticulum Stress-Induced apoptosis in renal tubular epithelial cells via regulation of the TLR4\/NF-kappaB and Nrf2\/HO-1 pathways. Inflammation. 2021;44:2323\u201332.","journal-title":"Inflammation"},{"key":"1760_CR18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1530\/rep.1.00095","volume":"127","author":"M Myers","year":"2004","unstructured":"Myers M, Britt KL, Wreford NG, Ebling FJ, Kerr JB. Methods for quantifying follicular numbers within the mouse ovary. Reproduction. 2004;127:569\u201380.","journal-title":"Reproduction"},{"key":"1760_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1477-7827-8-20","volume":"8","author":"I Ben-Aharon","year":"2010","unstructured":"Ben-Aharon I, Bar-Joseph H, Tzarfaty G, Kuchinsky L, Rizel S, Stemmer SM, Shalgi R. Doxorubicin-induced ovarian toxicity. Reprod Biol Endocrinol. 2010;8:20.","journal-title":"Reprod Biol Endocrinol"},{"key":"1760_CR20","doi-asserted-by":"publisher","first-page":"782","DOI":"10.18632\/aging.100363","volume":"3","author":"R Soleimani","year":"2011","unstructured":"Soleimani R, Heytens E, Darzynkiewicz Z, Oktay K. Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise. Aging. 2011;3:782\u201393.","journal-title":"Aging"},{"key":"1760_CR21","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1093\/humrep\/dem027","volume":"22","author":"D Meirow","year":"2007","unstructured":"Meirow D, Dor J, Kaufman B, Shrim A, Rabinovici J, Schiff E, Raanani H, Levron J, Fridman E. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod. 2007;22:1626\u201333.","journal-title":"Hum Reprod"},{"key":"1760_CR22","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/nm1197-1228","volume":"3","author":"GI Perez","year":"1997","unstructured":"Perez GI, Knudson CM, Leykin L, Korsmeyer SJ, Tilly JL. Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction. Nat Med. 1997;3:1228\u201332.","journal-title":"Nat Med"},{"key":"1760_CR23","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/GRF.0b013e3181f96b54","volume":"53","author":"D Meirow","year":"2010","unstructured":"Meirow D, Biederman H, Anderson RA, Wallace WH. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol. 2010;53:727\u201339.","journal-title":"Clin Obstet Gynecol"},{"key":"1760_CR24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/humupd\/dms022","volume":"18","author":"S Morgan","year":"2012","unstructured":"Morgan S, Anderson RA, Gourley C, Wallace WH, Spears N. How do chemotherapeutic agents damage the ovary? Hum Reprod Update. 2012;18:525\u201335.","journal-title":"Hum Reprod Update"},{"key":"1760_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/107155769900600502","volume":"6","author":"Z Blumenfeld","year":"1999","unstructured":"Blumenfeld Z, Avivi I, Ritter M, Rowe JM. Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women. J Soc Gynecol Investig. 1999;6:229\u201339.","journal-title":"J Soc Gynecol Investig"},{"key":"1760_CR26","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1038\/s44321-024-00124-z","volume":"16","author":"A Liugaila","year":"2024","unstructured":"Liugaila A, Stefansdottir A, Spears N. Can we manipulate the ovary\u2019s own metabolism to protect it from chemotherapy-induced damage? EMBO Mol Med. 2024;16:2274\u20135.","journal-title":"EMBO Mol Med"},{"key":"1760_CR27","doi-asserted-by":"publisher","first-page":"113306","DOI":"10.1016\/j.intimp.2024.113306","volume":"143","author":"W Huang","year":"2024","unstructured":"Huang W, Zhang H, Wang L, Zhang F, Ma M, Chen D, Wan X, Zhang Y, Cao C. Ulinastatin attenuates renal ischemia-reperfusion injury by inhibiting NLRP3 inflammasome-triggered pyroptosis. Int Immunopharmacol. 2024;143:113306.","journal-title":"Int Immunopharmacol"},{"key":"1760_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00005-023-00688-7","volume":"71","author":"J Qiao","year":"2023","unstructured":"Qiao J, Guo S, Huang X, Zhang L, Li F, Fan Y. Expression of Angiopoietin-2 in lung tissue of juvenile SD rats with Lipopolysaccharide-Induced acute lung injury and the role of Ulinastatin. Arch Immunol Ther Exp (Warsz). 2023;71:23.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"1760_CR29","doi-asserted-by":"publisher","first-page":"e822","DOI":"10.1002\/iid3.822","volume":"11","author":"M Guo","year":"2023","unstructured":"Guo M, Zhou B. Clinical efficacy of Ulinastatin in the treatment of unliquefied pyogenic liver abscess complicated by septic shock: A randomized controlled trial. Immun Inflamm Dis. 2023;11:e822.","journal-title":"Immun Inflamm Dis"},{"key":"1760_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.14715\/cmb\/2023.69.15.41","volume":"69","author":"L Liu","year":"2023","unstructured":"Liu L, Liu J, Wang J, Chen Y, Liu G. Ulinastatin protects against myocardial ischemia\/reperfusion injury in rats via rho\/rock signaling pathway. Cell Mol Biol (Noisy-le-grand). 2023;69:249\u201353.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"1760_CR31","doi-asserted-by":"crossref","unstructured":"Dogan GO, Erbas O. Exenatide improves cisplatin induced ovarian damage through NLRP3, Nrf-2, and TLR4 pathways. Cir Cir 2024.","DOI":"10.24875\/CIRUE.M23000810"},{"key":"1760_CR32","doi-asserted-by":"publisher","first-page":"17318","DOI":"10.1038\/s41598-024-67557-x","volume":"14","author":"F Li","year":"2024","unstructured":"Li F, Zhu F, Wang S, Hu H, Zhang D, He Z, Chen J, Li X, Cheng L, Zhong F. Icariin alleviates cisplatin-induced premature ovarian failure by inhibiting ferroptosis through activation of the Nrf2\/ARE pathway. Sci Rep. 2024;14:17318.","journal-title":"Sci Rep"},{"key":"1760_CR33","doi-asserted-by":"crossref","unstructured":"Harifi-Mood MS, Alemzadeh E, Barati D, Dehghani AH, Siroosi FZ, Aschner M, Samini F, Samarghandian S, Farkhondeh T. The role of Nrf2 in glioma: therapeutic targeting strategies. Curr Cancer Drug Targets 2025.","DOI":"10.2174\/0115680096331620250119111525"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01760-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01760-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01760-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T13:20:13Z","timestamp":1759152013000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01760-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1760"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01760-w","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was reviewed and approved by the Animal Experiment Ethics Committee of Jilin University (Approval No. SY2025-07-008). All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.KT202103225 is the animal ethics approval number for our preliminary experiments conducted during the project\uff08Grant No. YDZJ202201ZYTS293\uff09 application phase. SY2025-07-008 is the animal ethics approval number for our formal animal experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"207"}}